Table 1 Study population (n = 104)

Age (y-o)

54.9 ± 14.9

51.9 ± 15.5

62.2 ± 10.7*

55.0 ± 16.3

54.6 ± 12.1

Male

69 (66.3)

45 (60.8)

24 (80.0)*

44 (63.8)

25 (71.4)

Comorbidities

 t2DM

 HBP (mm/Hg)

 Obesity

 t2DM, HBP, Obesity

 Others^&

 None

10 (9.6)

15 (14.4)

13 (12.5)

17 (16.3)

13 (12.5)

36 (34.6)

6 (8.1)

8 (10.8)

11 (14.9)

10 (13.5)

10 (13.5)

29 (39.2)

4 (13.3)

7 (23.3)

2 (6.7)

7 (23.3)

3 (10.0)

7 (23.3)

5 (7.2)

10 (14.5)

8 (11.6)

9 (13.0)

11 (16.0)

26 (37.7)

5 (14.3)

5 (14.3)

5 (14.3)

8 (22.8)

2 (5.7)

10 (28.6)

Height (m)

Weight (kg)

BMI (kg/m²)

1.65 ± 0.08

75.6 ± 15.7

27.5 ± 4.5

1.65 ± 0.08

75.4 ± 16.2

27.5 ± 4.7

1.67 ± 0.08

75.9 ± 14.4

27.4 ± 4.0

1.65 ± 0.08

73.6 ± 14.5

27.0 ± 4.4

1.67 ± 0.08

79.6 ± 17.4

28.5 ± 4.4*

Leucocytes (x10³cells/µL)

Neutrophils (x10³cells/µL)

Lymphocytes (x10³cells/µL)

NtLR

8.62 ± 4.10

7.50 ± 4.57

0.98 ± 0.64

10.35 ± 8.97

8.14 ± 3.95

7.54 ± 4.75

1.00 ± 0.57

9.82 ± 8.76

9.85 ± 4.30*

7.41 ± 4.18

0.93 ± 0.82

11.65 ± 9.65

8.13 ± 4.16

7.61 ± 5.11

1.00 ± 0.73

10.43 ± 9.51

9.57 ± 3.86

7.30 ± 3.34

0.93 ± 0.43

10.22 ± 8.09

Mediators

 CRP (mg/L)

 Ferritin (mcg/dL)

72.4 ± 94.3

765 ± 742

71.6 ± 92.1

631 ± 535

72.3 ± 102.1

1141 ± 1070*

72.8 ± 98.2

689 ± 573

68.0 ± 88.3

882 ± 944

D-Dimer (ng/mL)

1631 ± 1602

1278 ± 1218

2080 ± 2067*

1256 ± 1254

2056 ± 2055*